Suppr超能文献

对于温哥华 B2 型假体周围股骨骨折,对于固定于抛光股骨假体周围的骨折,可以安全地采用内固定治疗。

Selected Vancouver B2 periprosthetic femoral fractures around cemented polished femoral components can be safely treated with osteosynthesis.

机构信息

Sir John Charnley Hip Surgery Unit, Institute of Orthopaedics Carlos E. Ottolenghi, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.

Adult Reconstructive Surgery Unit, Department of Orthopaedic Surgery, Sanatorio del Norte, Tucumán, Buenos Aires, Argentina.

出版信息

Bone Joint J. 2021 Jul;103-B(7):1222-1230. doi: 10.1302/0301-620X.103B7.BJJ-2020-1809.R1.

Abstract

AIMS

We aimed to compare the implant survival, complications, readmissions, and mortality of Vancouver B2 periprosthetic femoral fractures (PFFs) treated with internal fixation with that of B1 PFFs treated with internal fixation and B2 fractures treated with revision arthroplasty.

METHODS

We retrospectively reviewed the data of 112 PFFs, of which 47 (42%) B1 and 27 (24%) B2 PFFs were treated with internal fixation, whereas 38 (34%) B2 fractures underwent revision arthroplasty. Decision to perform internal fixation for B2 PFFs was based on specific radiological (polished femoral components, intact bone-cement interface) and clinical criteria (low-demand patient). Median follow-up was 36.4 months (24 to 60). Implant survival and mortality over time were estimated with the Kaplan-Meier method. Adverse events (measured with a modified Dindo-Clavien classification) and 90-day readmissions were additionally compared between groups.

RESULTS

In all, nine (8.01%) surgical failures were detected. All failures occurred within the first 24 months following surgery. The 24-month implant survival was 95.4% (95% confidence interval (CI) 89.13 to 100) for B1 fractures treated with internal fixation, 90% (95% CI 76.86 to 100) for B2 PFFs treated with osteosynthesis-only, and 85.8% (95% CI 74.24 to 97.36) for B2 fractures treated with revision THA, without significant differences between groups (p = 0.296). Readmissions and major adverse events including mortality were overall high, but similar between groups (p > 0.05). The two-year patient survival rate was 87.1% (95% CI 77.49 to 95.76), 66.7% (95% CI 48.86 to 84.53), and 84.2% (95% CI 72.63 to 95.76), for the B1 group, B2 osteosynthesis group, and B2 revision group, respectively (p = 0.102).

CONCLUSION

Implant survival in Vancouver B2 PFFs treated with internal fixation was similar to that of B1 fractures treated with the same method and to B2 PFFs treated with revision arthroplasty. Low-demand, elderly patients with B2 fractures around well-cemented polished femoral components with an intact bone-cement interface can be safely treated with internal fixation. Cite this article:  2021;103-B(7):1222-1230.

摘要

目的

我们旨在比较温哥华 B2 型假体周围股骨骨折(PFF)经内固定治疗与 B1 型 PFF 经内固定治疗和 B2 型骨折行翻修关节置换术的患者的植体存活率、并发症、再入院率和死亡率。

方法

我们回顾性分析了 112 例 PFF 患者的数据,其中 47 例(42%)为 B1 型,27 例(24%)为 B2 型,38 例(34%)为 B2 型骨折行翻修关节置换术。B2 型 PFF 行内固定治疗的决策是基于特定的影像学(抛光股骨组件、完整的骨水泥界面)和临床标准(低需求患者)。中位随访时间为 36.4 个月(24 至 60 个月)。采用 Kaplan-Meier 法估计植体存活率和死亡率随时间的变化。此外,还比较了各组之间的不良事件(采用改良的 Dindo-Clavien 分类测量)和 90 天再入院率。

结果

共发现 9 例(8.01%)手术失败。所有失败均发生在术后 24 个月内。B1 型骨折内固定治疗的 24 个月植体存活率为 95.4%(95%置信区间(CI)89.13 至 100),B2 型 PFF 单纯内固定治疗的 24 个月植体存活率为 90%(95%CI 76.86 至 100),B2 型骨折行翻修 THA 治疗的植体存活率为 85.8%(95%CI 74.24 至 97.36),各组之间无显著差异(p = 0.296)。再入院率和包括死亡率在内的主要不良事件总体较高,但各组之间无差异(p>0.05)。B1 组、B2 型内固定组和 B2 型翻修组的两年患者生存率分别为 87.1%(95%CI 77.49 至 95.76)、66.7%(95%CI 48.86 至 84.53)和 84.2%(95%CI 72.63 至 95.76)(p = 0.102)。

结论

温哥华 B2 型 PFF 经内固定治疗的植体存活率与 B1 型骨折经相同方法治疗和 B2 型骨折行翻修关节置换术的植体存活率相似。对于周围有固定良好的抛光股骨组件且骨水泥界面完整、低需求的老年 B2 型骨折患者,可以安全地采用内固定治疗。

引用本文

2021;103-B(7):1222-1230.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验